NeueHealth, Inc.
$6.75+0.00%(+$0.00)
TickerSpark Score
60/100
73
Valuation
50
Profitability
55
Growth
44
Health
80
Momentum
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a NEUE research report →
52-Week Range77% of range
Low $3.79
Current $6.75
High $7.66
Companywww.neuehealth.com
NeueHealth, Inc. , a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions.
- CEO
- George Lawrence Mikan III
- IPO
- 2021
- Employees
- 986
- HQ
- Doral, FL, US
Price Chart
+29.56% · this period
Valuation
- Market Cap
- $60.94M
- P/E
- -1.56
- P/S
- 0.09
- P/B
- -0.13
- EV/EBITDA
- 9.70
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 25.14%
- Op Margin
- -1.90%
- Net Margin
- -5.77%
- ROE
- 8.60%
- ROIC
- 7.52%
Growth & Income
- Revenue
- $936.66M · -19.31%
- Net Income
- $-134,680,000 · 88.30%
- EPS
- $-22.65 · 84.99%
- Op Income
- $-107,410,000
- FCF YoY
- 95.40%
Performance & Tape
- 52W High
- $7.66
- 52W Low
- $3.79
- 50D MA
- $6.70
- 200D MA
- $6.74
- Beta
- 0.60
- Avg Volume
- 6.47K
Get TickerSpark's AI analysis on NEUE
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Oct 2, 25 | Matushak Jay | sell | 40,431 |
| Oct 2, 25 | Matushak Jay | sell | 6,340 |
| Oct 2, 25 | Bessemer Venture Partners IX L.P. | sell | 999,218 |
| Oct 2, 25 | Bessemer Venture Partners IX L.P. | sell | 8,500 |
| Oct 2, 25 | Kraus Stephen | sell | 0 |
| Oct 2, 25 | Kraus Stephen | sell | 0 |
| Oct 2, 25 | Craig Jeffery Michael | sell | 100,000 |
| Oct 2, 25 | Craig Jeffery Michael | sell | 20,103 |
| Oct 2, 25 | Orozco Tomas | sell | 48,000 |
| Oct 2, 25 | Orozco Tomas | sell | 29,325 |
Our NEUE Coverage
We haven't published any research on NEUE yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate NEUE Report →